scispace - formally typeset
C

Carlo de Asmundis

Researcher at Vrije Universiteit Brussel

Publications -  384
Citations -  6022

Carlo de Asmundis is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Medicine & Atrial fibrillation. The author has an hindex of 37, co-authored 265 publications receiving 4738 citations. Previous affiliations of Carlo de Asmundis include Free University of Brussels & Université libre de Bruxelles.

Papers
More filters
Journal ArticleDOI

Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.

TL;DR: ICD therapy was an effective strategy in Brugada syndrome, treating potentially lethal arrhythmias in 17% of patients during long-term follow-up, and risk stratification by electrophysiologic study may identify asymptomatic patients at risk for arrhythmic events and could be helpful in investigating syncope not related to VAs.
Journal ArticleDOI

Single 3-minute freeze for second-generation cryoballoon ablation: One-year follow-up after pulmonary vein isolation

TL;DR: A single 3-minute freeze is highly effective, determining an atrial tachyarrhythmia freedom of 80.4% at 1-year follow-up, and Routine use of an "insurance freeze" may not be needed.
Journal ArticleDOI

Inferior and Lateral Electrocardiographic Repolarization Abnormalities in Brugada Syndrome

TL;DR: Inferior-lateral early repolarization pattern occurs spontaneously relatively frequently in BS, and for the first time 3 patients in whom the class I AAD–provoked coved Brugada pattern was only observed in the inferior leads.
Journal ArticleDOI

One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon.

TL;DR: The second generation Cryoballoon Advance was designed with technical modifications resulting in a larger and more uniform zone of freezing on the balloon's surface aiming at procedural outcome improvement in the setting of atrial fibrillation (AF) ablation.
Journal ArticleDOI

Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up

TL;DR: The CB-A is very effective in producing PVI and affords freedom from AF at 12 months follow-up in 83% of patients affected by drug-resistant PAF following a 3-month BP.